Target intelligence / Profile preview

S-phase kinase-associated protein 2-Cyclin-dependent kinase regulatory subunit 1 protein-protein interface (Skp2-Cks1 interface)

Target
Skp2-Cks1 interface
Molecular classification
Protein-protein interface, E3 ubiquitin ligase complex component, F-box protein complex
01

Overview

The S-phase kinase-associated protein 2 (Skp2)-Cyclin-dependent kinase regulatory subunit 1 (Cks1) protein-protein interface is a pivotal regulatory node within the SCF^Skp2 E3 ubiquitin ligase complex (UniProt P63272, P61024). This interface is specifically required for the recruitment and polyubiquitination of the cyclin-dependent kinase inhibitor p27^Kip1, a key negative regulator of the G1/S phase transition (PubMed: 22854781). In various malignancies, including breast and prostate cancers, the overexpression of Skp2 and Cks1 facilitates the accelerated degradation of p27, driving oncogenic cell proliferation and poor clinical outcomes (PubMed: 23839240). Targeting this interface with small molecules aims to stabilize p27 levels and restore cell cycle control. Experimental inhibitors like Compound 67 and SZL-P1-41 have demonstrated the feasibility of disrupting this interaction to induce cell cycle arrest and apoptosis in cancer cells (PubMed: 22854781, 25201210). Unlike general proteasome inhibitors, targeting the Skp2-Cks1 interface offers a more selective strategy for modulating the ubiquitin-proteasome system in oncology. The structural basis of this interface involves the binding of Cks1 to the leucine-rich repeat domain of Skp2, creating a unique pocket for the phosphorylated Thr187 residue of p27 (PubMed: 16209941). Therapeutic development focuses on identifying drug-like molecules that can penetrate this shallow interface to prevent substrate binding without affecting other SCF complex functions.

Other names
Skp2-Cks1 complexSCF-Skp2-Cks1 interfacep27-binding pocket of Skp2-Cks1Skp2-Cks1-p27 interaction site
02

Mechanism of action

Small molecule inhibition of the protein-protein interaction between Skp2 and its cofactor Cks1, or the blocking of the substrate-binding pocket formed by the Skp2-Cks1 complex, which prevents the ubiquitination and subsequent proteasomal degradation of the tumor suppressor p27^Kip1.

03

Biological functions

Cell cycle regulationUbiquitin-dependent protein catabolic processG1/S transition of mitotic cell cycleProtein ubiquitinationProteasomal protein degradation
04

Disease associations

CancerBreast cancerProstate cancerColorectal cancerLymphomaLung cancer
05

Safety considerations

Potential for off-target effects on other SCF complexesSystemic toxicity from cell cycle inhibition in healthy tissuesTechnical difficulty in achieving high-affinity binding to shallow protein interfacesPotential for compensatory upregulation of other E3 ligases
06

Interacting drugs

Compound 67

5 more in the full profile.

07

Biomarkers

p27^Kip1 protein levelsSkp2 expressionCks1 expressionCyclin E levelsKi-67 proliferation index

Beyond the preview

Go deeper on S-phase kinase-associated protein 2-Cyclin-dependent kinase regulatory subunit 1 protein-protein interface (Skp2-Cks1 interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S-phase kinase-associated protein 2-Cyclin-dependent kinase regulatory subunit 1 protein-protein interface (Skp2-Cks1 interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call